Replies to post #6522 on Galena Biopharma fka GALE

[cdaniel394]

Here we go.



Items of Business

We are holding the Annual Meeting for the following purposes, which are described in more detail in our Proxy Statement:



• To elect three directors to serve until the 2018 annual meeting of stockholders;



• To approve an increase in our authorized common stock;



• To approve an increase in the shares available under our 2007 Incentive Plan;



• To approve, by non-binding vote, the compensation of our named executive officers;



• To ratify the appointment of Moss Adams LLP as our independent registered public accounting firm for 2015; and